ENTITY
Telix Pharmaceuticals

Telix Pharmaceuticals (TLX AU)

151
Analysis
Health Care • Australia
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
more
bullish•Santos Ltd
•10 Jul 2025 15:00•Syndicated
Logo
FNArena
375 Views
Share
bullish•DroneShield Ltd
•03 Jul 2025 14:01•Syndicated

Rudi's View: Charter Hall, Droneshield, Pinnacle, WiseTech & More

Update on changes to and revisions of analysts' Best Ideas and Conviction Calls, as well as Model Portfolio compositions

Logo
FNArena
366 Views
Share
bullish•Life360 Inc
•27 Jun 2025 00:00•Syndicated

Rudi's View: CBA, Life360, ResMed, Zip & More

Update on changes to and revisions of analysts' Best Ideas and Conviction Calls, as well as Model Portfolio compositions

Logo
FNArena
319 Views
Share
•05 Nov 2020 15:38•Issuer-paid

Telix Pharmaceuticals - Telix signs a big China deal

Telix announced on 2 November 2020 that it has entered into a licensing agreement with China Grand Pharmaceutical (CGP) for the greater Chinese...

Share
•28 Sep 2020 21:20•Issuer-paid

Telix Pharmaceuticals - TLX591-CDx NDA submitted

On 24 September 2020 Telix announced it had submitted its NDA to the FDA for approval of TLX591-CDx, its positron emission tomography (PET) imaging...

Share
x